DFI Co., Ltd. recalls QUCARE Total Cholesterol in vitro diagnostic test REF: 6407
- Recall date
- April 2, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2085-2026
- FDA classification
- Class II
- Brand / firm
- DFI Co., Ltd.
- Sold / distributed
- Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.
Why it was recalled
The devices were distributed without required FDA premarket clearance or approval.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
QUCARE Total Cholesterol in vitro diagnostic test REF: 6407
Get recall alerts
Free email alert whenever DFI Co., Ltd. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: DFI Co., Ltd.